Oxford university and AstraZeneca have begun work to produce an Omicron-targeted version of their coronavirus vaccine, joining the ranks of their peers who are studying the potential for adapting formulations of their shots in case they become necessary to tackle the variant.
牛津大学(Oxford university)和阿斯利康(AstraZeneca)已经开始致力于生产奥密克戎(ommicron)靶向的冠状病毒疫苗，加入了他们的同行的行列，这些同行正在研究调整疫苗配方的潜力，以防有必要应对这种变体。
您已阅读9%（392字），剩余91%（3748字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。